$309.18+57.02% · 3M
Moving avg
1W-4.01%
1M+11.47%
3M+65.90%
6M+49.92%
YTD+35.11%
1Y+95.14%
3Y+443.28%
5Y+205.82%
52-week range
$131.81100% of range$288.04
Company health
Value0/6
Growth3/6
Profitability2/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- Revenue compounding 28% a year
- Net cash on the balance sheet
Risks
- Trades 11% above the average analyst target
- Currently unprofitable
- More volatile than the market (beta 1.5)
Key statistics
Valuation
Market cap
$44.28B
Enterprise value
$36.67B
P/E ratio (TTM)
-160.73x
P/S ratio (TTM)
15.00x
EV/EBITDA
-163.89x
Per share & returns
EPS (TTM)
-$1.60
Dividend yield
0.00%
Beta (1Y)
1.50
30-day change
+11.47%
Trading
Volume (24h)
374.16K
Previous close
$315.96
Shares outstanding
143.22M
About Natera, Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Symbol
NTRA
Natera, Inc. is a large-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NASDAQ (United States) and trade under the ticker NTRA.
Frequently asked questions
What is Natera, Inc.'s market cap?
Natera, Inc. (NTRA) has a market capitalization of $44.28B.
What sector is Natera, Inc. in?
Natera, Inc. operates in the Healthcare sector, Medical - Diagnostics & Research industry.
What exchange does NTRA trade on?
NTRA trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,216.03-0.35%
$1.15T cap
Johnson & JohnsonJNJ
$261.33+0.18%
$629.78B cap
AbbVie Inc.ABBV
$250.78+0.81%
$443.08B cap
UnitedHealth Group IncorporatedUNH
$402.12-0.86%
$365.18B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.53+1.21%
$332.26B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap